Depression during pregnancy and postpartum

Clinical Obstetrics and Gynecology

Volumn 55, Issue 3, 2012, Pages 788-797

  Toohey, Julianne ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anxiety; mood disorders; postpartum depression

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE; CLONAZEPAM; CLOZAPINE; FLUOXETINE; IMIPRAMINE; ISOCARBOXAZID; LITHIUM; NORTRIPTYLINE; PAROXETINE; PHENELZINE; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE;

ANENCEPHALUS; ANXIETY DISORDER; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CHILD ABUSE; CYANOSIS; DOMESTIC VIOLENCE; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DSM-IV; EBSTEIN ANOMALY; EDUCATIONAL STATUS; GASTROINTESTINAL SYMPTOM; HEART ARRHYTHMIA; HUMAN; INFANTICIDE; IRRITABILITY; MOTOR DYSFUNCTION; NEGLECT; NONHUMAN; OMPHALOCELE; PSYCHOTHERAPY; PUERPERAL DEPRESSION; PUERPERAL PSYCHOSIS; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SOCIAL STATUS; SUICIDE; TREMOR; UNEMPLOYMENT;

ANTIDEPRESSIVE AGENTS; ANXIETY; BREAST FEEDING; DEPRESSION, POSTPARTUM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOTHERAPY; RISK FACTORS;

EID: 84864409289     PISSN: 00099201     EISSN: 15325520     Source Type: Journal    
DOI: 10.1097/GRF.0b013e318253b2b4     Document Type: Article

References (41)

1. Kessler RC, Berglund P, Demler O, et al. The epidemiologyofmajor depressive disorder. JAMA. 2003;30:95-105.
2. Smith MV, Rosenheck RA, Cavaleri MA, et al. Screening for and detection of depression, panic disorder and PTSD in public sector obstetrics clinics. Psychiatr Serv. 2004;55:407-414. (Pubitemid 38445587)
3. O'Hara MW, Zekoski EM, Philipps LH, et al. Controlled prospective study of postpartum mood disorders: comparison of childbearing and non-childbearing women. J Abnorm Psychol. 2009;99:3-15.
4. Kendall RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry. 2007;150: 662-673.
5. Robertson E, Sherry G, Wallington T, et al. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry. 2004;26:289-295. (Pubitemid 38962393)
6. Josefsson A, Angelsioo L, Berg G, et al. Obstetric, somatic and demographic risk factors for post-partum depressive symptoms. Obstet Gynecol. 2002;99:223-228. (Pubitemid 34113993)
7. Cohen L, Altshuler L, Harlow B, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA. 2006;295:499-507. (Pubitemid 43200344)
8. O'Hara MW, Swain AM. Rates and risk of post-partum depression-a meta-analysis. Int Rev Psychiatry. 1996;8:37-54.
9. Atkinson AK, Rickle AU. Depression in women: the postpartum experience. Issues Mental Health Nurs. 1983;5:197-218.
10. O'Hare MW, Neunaber DJ, Zekoski EM. Prospective study of postpartum depression: prevalence, course, and predictive factors. J Abnorm Psychol. 1984;93:158-171.
11. Pitt B. Maternity blues. Br J Psychiatry. 1973;122: 431-433.
12. Ross LE, McLean LM. Anxiety disorders during pregnancy and postpartum-a systematic review. J Clin Psychiatry. 2006;67:1285-1298. (Pubitemid 44439704)
13. Fava M, Rush AJ, ALpert JE, et al. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report. Am J Psychiatry. 2008;165:342-351. (Pubitemid 351704490)
14. Viguera AC, Whitfield T, Baldessarini RJ. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry. 2007;64: 1817-1824. quiz 1923.
15. Schmidt LA, Greenberg BD, Holzman GB, et al. Treatment of depression by obstetrician-gynecologists: a survey study. J Am Coll Obstet Gynecol. 1997;90:296-300. (Pubitemid 27318850)
16. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10 item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987;150:782-786. (Pubitemid 17082036)
17. Cox JL, Chapman G, Murray D, et al. Validation of the Edinburgh postnatal depression scale (EPDS) in non-postnatal women. J Affect Disord. 1996;39:185-189. (Pubitemid 26291784)
18. Pastuszak A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcomes following first trimester exposure to fluoxetine. JAMA. 1993;269: 2246-2248. (Pubitemid 23120281)
19. Chambers C, Johnson K, Dick L, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med. 1996;335:1010-1015. (Pubitemid 26338730)
20. Kulin N, Pastuszak A, Sage S, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA. 1998;279: 609-610. (Pubitemid 28110208)
21. Goldstein D, Corbin L, Sundell K. Effects of first trimester fluoxetine exposure on the newborn. Obstet Gynecol. 1997;89:713-718. (Pubitemid 27184852)
22. Ericson A, Kallen B, Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol. 1999;55: 503-508. (Pubitemid 29446550)
23. Wisner K, Gelenberg A, Leonard H, et al. Phar-macologic treatment of depression during pregnancy. JAMA. 1999;282:1264-1269.
24. Addis A, Koren G. Safety offluoxetine during the first trimester of pregnancy: a meta-analytic review of epidemiologic studies. Psychol Med. 2000;30:89-94. (Pubitemid 30099121)
25. Alwan S, Reefhuis J, Rasmussen S, et al. Use of selective serotonin reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med. 2007;356:2684-2692. (Pubitemid 47001036)
26. Louik C, Lin A, Werler M, et al. First trimester use of selective reuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356:2675-2683. (Pubitemid 47001035)
27. Einarson A, Pistelli A, DeSantis M, et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry. 2008;165:749-752. (Pubitemid 351810544)
28. Moses-Kolko E, Bogen D, Perel J, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors. JAMA. 2005;293:2372-2383.
29. Nordeng H, Spigset O. Treatment with selective serotonin reuptake inhibitors in the third trimester of pregnancy. Drug Saf. 2005;28:565-581. (Pubitemid 41003046)
30. Sanz E, De-las-Cuevas C, Kiuru A, et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet. 2005;365:482-487. (Pubitemid 40215730)
31. Chambers C, Hernandez-Diaz S, Van Marter L, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med. 2006;354:579-587. (Pubitemid 43209105)
32. Andrade S, McPhillips H, Loren D, et al. Anti-depressant use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf. 2009;18:246-252.
33. Nulman I, Rovet J, Stewart D, et al. Child development following exposure to tricyclic antidepres-sants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry. 2002;159:1889-1895. (Pubitemid 35283255)
34. Woody J, London WL, Wilbanks GD, Jr. Lithium toxicity in a newborn. Pediatrics. 1971;47: 94-96.
35. Numan I, Rovert J, Stewart D, et al. Neurodevel-opment of children exposed in uteror to antidepressant drugs. N Engl J Med. 1997;336: 258-262. (Pubitemid 27044627)
36. Wisner K, Perel J, Findling R. Antidepressant treatment during breast-feeding. Am J Psychiatry. 1996;153:1132-1137. (Pubitemid 26299830)
37. Murray L, Cooper P. Effects of postnatal depression on infant development. Arch Dis Child. 1997;77:99-101. (Pubitemid 27398209)
38. Field T. The treatment of depressed mothers and their infants. In: Murray L, Cooper PJ. eds. Post-partum Depression and Child Development. NY: Guilford; 1997: 221-235.
39. Field T, Healy B, Goldstein S, et al. Behavior-state matching and synchrony in mother-infant interactions in non depressed versus depressed dyads. Dev Psychol. 1990;26:7-14.
40. Gunlicks M, Weissman M. Change in child psy-chopathology with improvement in parental depression: a systematic review. J Am Acad Child Adolesc Psychiatry. 2008;47:379-389. (Pubitemid 351450736)
41. Logsdon M, Wisner K, Hanusa B. Does maternal role functioning improve in women with postpar-tum depression after antidepressant treatment? J Womens Health. 2009;18:85-90.